Truist Financial
CATX icon

Truist Financial’s Perspective Therapeutics CATX Stock Holding History

Truist Financial’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,342
Closed -$6K – 2640
2020
Q4 		$6K Hold
1,342
– – ﹤0.01% 2536
2020
Q3 		$8K Hold
1,342
– – ﹤0.01% 2429
2020
Q2 		$7K Hold
1,342
– – ﹤0.01% 2392
2020
Q1 		$7K Hold
1,342
– – ﹤0.01% 2360
2019
Q4 		$8K Buy
+1,342
New +$5.88K ﹤0.01% 2482

Other funds holding CATX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HPWM
Highland Private Wealth Management Bellevue, Washington $620M AUM 18.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Truist Financial's CATX Position: Q1 2021 in Review

Truist Financial sold out of Perspective Therapeutics (CATX) in Q1 2021, closing a stake of 1,342 shares — an estimated $6K sold.

Truist Financial first reported a position in CATX in Q4 2019 and held it in 5 quarters. The position peaked at $8K in Q3 2020. 57 funds tracked by Wall St. Rank hold CATX as of Q1 2021.

  • Truist Financial reported no remaining Perspective Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Truist Financial sold 1,342 Perspective Therapeutics shares in Q1 2021, an estimated $6K.
  • Truist Financial first reported a position in Perspective Therapeutics in Q4 2019 and held it in 5 quarters.
  • Truist Financial's Perspective Therapeutics position peaked at $8K in Q3 2020.
  • 57 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2021.

Based on Truist Financial's 13F filing for Q1 2021, filed 17 May 2021.